Stay updated with breaking news from Dons Dizon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The combination of nivolumab and ipilimumab improved responses as well as survival outcomes in patients with ovarian or gynecologic clear cell carcinomas.
Don S. Dizon, MD, FACP, FASCO, discusses future directions for precision medicine approaches in ovarian cancer.
Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest.
Don S. Dizon, MD, on the prevalence of sexual complications in patients with breast cancer.
Over the last year, prestigious national and international organizations recognized Brown faculty for their research, scholarship and leadership.